Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Eva Hoster, Ulrich Mey et al.|The Lancet|2024Cited by 135
Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemiaD. Müller, Martin Müller, Stefan Wirths et al.|Journal of Leukocyte Biology|2018Cited by 12
110 | HIGH PFS WITH LOW INFIELD RECURRENCES AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE NODAL FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3)Klaus Herfarth, M. Dreyling, Christian Schölz et al.|Hematological Oncology|2025Cited by 0